-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Vitro Biopharma, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Oct 2012 to 31 Oct 2025.
- Vitro Biopharma, Inc. Amortization of Intangible Assets for the quarter ending 31 Oct 2025 was $7,619, a 41% decline year-over-year.
- Vitro Biopharma, Inc. Amortization of Intangible Assets for the twelve months ending 31 Oct 2025 was $30,476, a 52% decline year-over-year.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2025 was $30,476, a 52% decline from 2024.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2024 was $63,702, a 52% decline from 2023.
- Vitro Biopharma, Inc. annual Amortization of Intangible Assets for 2023 was $131,736, a 0% increase from 2022.